An article in the March 2nd New York Times entitled "Pfizer Ad Stirs Talk of Entry into Rivals' Fight" discusses an advertisement that Pfizer Inc. recently placed in a French newspaper and the role it might play in the contested unsolicited takeover bid by Sanofi-Synthelabo for Aventis SA. According to the article, "[i]t is common practice in France to take out advertisements that boast of a company's strengths before attempting a takeover. Merger specialists said that the timing of the Pfizer ad, which comes as the legality of the Sanofi bid is being debated in a French courtroom, was puzzling. 'It has to be more than coincidence,' said Eric Cafritz, a partner with Fried, Frank, Harris, Shriver & Jacobson [LLP], who is based in Paris. 'In these contested French bids, publicity is put to strategic use.'"